Compare RACE & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RACE | COR |
|---|---|---|
| Founded | 1947 | 2001 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.2B | 68.5B |
| IPO Year | 2015 | N/A |
| Metric | RACE | COR |
|---|---|---|
| Price | $338.48 | $329.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 13 |
| Target Price | ★ $495.00 | $380.54 |
| AVG Volume (30 Days) | 761.6K | ★ 1.1M |
| Earning Date | 02-10-2026 | 02-04-2026 |
| Dividend Yield | ★ 1.04% | 0.66% |
| EPS Growth | ★ 13.13 | 5.71 |
| EPS | ★ 10.52 | 7.96 |
| Revenue | $8,306,934,179.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $8.84 | $7.19 |
| Revenue Next Year | $5.97 | $6.19 |
| P/E Ratio | ★ $31.44 | $45.45 |
| Revenue Growth | ★ 9.52 | 9.31 |
| 52 Week Low | $328.00 | $237.71 |
| 52 Week High | $519.10 | $377.54 |
| Indicator | RACE | COR |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 35.61 |
| Support Level | $328.00 | $349.49 |
| Resistance Level | $338.40 | $366.15 |
| Average True Range (ATR) | 5.57 | 8.95 |
| MACD | 0.15 | -0.80 |
| Stochastic Oscillator | 38.15 | 7.32 |
Ferrari designs, engineers, and manufactures some of the world's most expensive luxury cars. With supply carefully controlled to be below demand and a brand steeped in decades of motor racing history, a Ferrari is viewed as a status symbol. In 2024, the company sold 13,752 vehicles at an average price over EUR 480,000 with more than 70% of its vehicles being sold to existing Ferrari clients. Eighty-six percent of revenue is generated from the sale of cars and spare parts and 10% from sponsorship, commercial, and brand activities including racing and lifestyle activities. In 2024, the Europe, Middle East, and Africa region accounted for 47% of revenue, the Americas was 33%, mainland China, Hong Kong, and Taiwan was 8%, and the rest of Asia was 12%.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.